Stephan Harbarth

发表

Teaching Adequate Prehospital Use of Personal Protective Equipment During the COVID-19 Pandemic: Development of a Gamified e-Learning Module

Mélanie Suppan, Birgit Gartner, Eric Golay, 2020, JMIR serious games.

Zum Reformbedarf im GmbH-Recht: Generalrevision oder punktuelle Fortentwicklung?

Stephan Harbarth, 2016 .

Application of Information Technology: Rapid Identification of Hospitalized Patients at High Risk for MRSA Carriage

R. Scott Evans, James F. Lloyd, Matthew H. Samore, 2008, J. Am. Medical Informatics Assoc..

Unternehmensorganisation und Vertrauensgrundsatz im Aktienrecht

Stephan Harbarth, 2017 .

Implementing New Diagnostic Tools for Antimicrobial Stewardship

Stephan Harbarth, 2014 .

Exploring the evidence base for national and regional policy interventions to combat resistance

Stephan Harbarth, Osman A Dar, Rumina Hasan, 2016, The Lancet.

Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action

Herman Goossens, Stephan Harbarth, Didier Pittet, 2012, Antimicrobial Resistance and Infection Control.

Hand hygiene practices and adherence determinants in surgical wards across Europe and Israel: a multicenter observational study.

Hugo Sax, Stephan Harbarth, Didier Pittet, 2011, American journal of infection control.

Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE’s STAT-Net

Leonhard Held, Stephan Harbarth, Stavros Nikolakopoulos, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective.

Stephan Harbarth, Johan W Mouton, John Turnidge, 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Antimicrobial resistance: one world, one fight!

Herman Goossens, Stephan Harbarth, Didier Pittet, 2015, Antimicrobial Resistance and Infection Control.

Nursing resources: a major determinant of nosocomial infection?

Hugo Sax, Stéphane Hugonnet, Stephan Harbarth, 2004, Current opinion in infectious diseases.

Antimicrobial Resistance Determinants and Future Control

Matthew H. Samore, Stephan Harbarth, M. Samore, 2005, Emerging infectious diseases.

Randomized, Placebo-Controlled, Double-Blind Trial To Evaluate the Efficacy of Mupirocin for Eradicating Carriage of Methicillin-Resistant Staphylococcus aureus

Stephan Harbarth, Didier Pittet, Raymond Auckenthaler, 1999, Antimicrobial Agents and Chemotherapy.

G-CSF and IL-8 for early diagnosis of sepsis in neonates and critically ill children – safety and cost effectiveness of a new laboratory prediction model: study protocol of a randomized controlled trial [ISRCTN91123847]

Stephan Harbarth, Oskar Baenziger, J. Fischer, 2004, Critical care.

Interventional study to evaluate the impact of an alcohol-based hand gel in improving hand hygiene compliance

Matthew H Samore, Stephan Harbarth, Didier Pittet, 2002, The Pediatric infectious disease journal.

“Antibiotics Are Not Automatic Anymore”—The French National Campaign To Cut Antibiotic Overuse

Stephan Harbarth, Benedikt Huttner, S. Harbarth, 2009, PLoS medicine.

Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of bias.

Stephan Harbarth, Martin Schumacher, Jan Beyersmann, 2012, Journal of clinical epidemiology.

Health-care workers: source, vector, or victim of MRSA?

Stephan Harbarth, S. Harbarth, W. Albrich, 2008, The Lancet. Infectious diseases.

Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients.

Hugo Sax, Stephan Harbarth, Didier Pittet, 2008, JAMA.

Analysis of the clinical antibacterial and antituberculosis pipeline.

John H Rex, Stephan Harbarth, Peter Beyer, 2019, The Lancet. Infectious diseases.

Contact Precautions for Preventing Nosocomial Transmission of Extended-Spectrum β Lactamase-Producing Escherichia coli: A Point/Counterpoint Review.

Stephan Harbarth, Sarah Tschudin-Sutter, Nico T Mutters, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Use of benchmarking and public reporting for infection control in four high-income countries.

Stephan Harbarth, Didier Pittet, Alison Holmes, 2011, The Lancet. Infectious diseases.

The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study

Stefan Hagel, Stephan Harbarth, Martin Schumacher, 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

The effect of improved hand hygiene on nosocomial MRSA control

Stephan Harbarth, Didier Pittet, Kalisvar Marimuthu, 2014, Antimicrobial Resistance and Infection Control.

Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study

Stephan Harbarth, Bara Ricou, Didier Pittet, 2006, Critical care.

Variation in antibiotic use among and within different settings: a systematic review

Stephan Harbarth, Vera Vlahović-Palčevski, Céline Pulcini, 2018, The Journal of antimicrobial chemotherapy.

Methicillin-resistant Staphylococcus aureus control in the 21st century: beyond the acute care hospital

Stephan Harbarth, Benedikt Huttner, S. Harbarth, 2008, Current opinion in infectious diseases.

Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?

Stephan Harbarth, S. Harbarth, Marlieke E A de Kraker, 2016, PLoS medicine.

The Importance of Good Data, Analysis, and Interpretation for Showing the Economics of Reducing Healthcare-Associated Infection

Stephan Harbarth, Adrian G. Barnett, Matthew Samore, 2011, Infection Control & Hospital Epidemiology.

Antibiotic Selection Pressure and Resistance in Streptococcus pneumoniae and Streptococcus pyogenes

Stephan Harbarth, Dominique L. Monnet, S. Harbarth, 2004, Emerging infectious diseases.

Evaluating the probability of previously unknown carriage of MRSA at hospital admission.

Hugo Sax, Stephan Harbarth, Didier Pittet, 2006, The American journal of medicine.

Evaluation of Molecular Assays for Rapid Detection of Methicillin-Resistant Staphylococcus aureus

Geert Molenberghs, Herman Goossens, Stephan Harbarth, 2010, Journal of Clinical Microbiology.

Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis.

Stephan Harbarth, Didier Pittet, D. Pittet, 2003, The American journal of medicine.

Estimating the cost of health care-associated infections: mind your p's and q's.

Stephan Harbarth, Nicholas Graves, Jan Beyersmann, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.